secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001193125-25-258519
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q1 FY2026 revenue +9% to $1.34B; non-GAAP EPS $2.55 (+16%); dividend $0.60
--------------------------------------------------------------------------------

- Revenue $1,335.6M (+9% YoY, +8% constant currency); diluted EPS $2.37, non-GAAP EPS $2.55 (+16%).
- Gross margin up 290 bps to 61.5%; non-GAAP gross margin 62.0% (up 280 bps).
- Operating cash flow $457M; income from operations +15% (+19% non-GAAP).
- Board declared quarterly dividend of $0.60 per share, payable Dec 18 to holders of record Nov 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312525258519/0001193125-25-258519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312525258519/d92301d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-258519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer